
Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China. …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

